Atlas Trials

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730

Clinical trial NCT03054194 · COMPLETED

Trial details

NCT number
NCT03054194
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2017-01-31
Primary completion
2017-03-02
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.